• Take Glynux MV 1.2 Tablet whole with water
• Do not crush, chew, or divide it
• Always take with food to minimise gastrointestinal discomfort
• Follow the doctor's instructions regarding dosage and duration of use
Glynux MV 1.2 Tablet is primarily used for the management of type 2 diabetes mellitus in adults. This medication belongs to the class of antidiabetic agents.
Glynux MV 1.2 Tablet is prescribed for:
• Improving glycaemic control in adults with type 2 diabetes mellitus
• Utilisation as a part of combination therapy with diet and exercise to enhance blood glucose control
• Aiding in the management of type 2 diabetes when other medications are inadequate
• Take Glynux MV 1.2 Tablet whole with water
• Do not crush, chew, or divide it
• Always take with food to minimise gastrointestinal discomfort
• Follow the doctor's instructions regarding dosage and duration of use
Glynux MV 1.2 Tablet is taken orally.
The side effects of Glynux MV 1.2 Tablet may include:
• Hypoglycaemia (low blood sugar levels)
• Nausea and vomiting
• Abdominal discomfort
• Dyspepsia (indigestion)
• Diarrhoea
Glynux MV 1.2 Tablet comprises three active components that work synergistically to regulate blood glucose levels:
• Glimepiride (1 mg): A sulfonylurea that stimulates pancreatic beta cells to release insulin, thereby lowering blood sugar levels.
• Voglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the breakdown of carbohydrates in the intestines, thus reducing postprandial blood glucose levels.
• Metformin (500 mg): A biguanide that decreases hepatic glucose production, reduces intestinal glucose absorption, and enhances insulin sensitivity by promoting peripheral glucose uptake and utilisation.
Exercise caution and consult your doctor before taking the medication during pregnancy.
Consult your doctor prior to commencing this medication while breastfeeding.
Alcohol intake should be avoided as it may enhance the effects of metformin on lactate metabolism.
Use with caution if liver function is impaired; it is not recommended for those with severe liver disease.
Contraindicated in individuals with significant renal impairment; consult your doctor for guidance.
If symptoms such as dizziness or weakness occur, refrain from engaging in such activities and consult your doctor.
Avoid this medication if you have known allergies to glimepiride, metformin, voglibose, or any other components of the medication.
Not recommended for individuals under 18 years of age; consult your doctor for guidance.
Older patients should use this medication under medical supervision due to increased sensitivity to side effects.
Drug-Drug Interactions
• Cationic Agents: May decrease metformin excretion, resulting in elevated metformin levels.
• Hyperglycaemic Agents: Such as corticosteroids and oestrogens, can raise blood glucose levels, reducing the efficacy of Glynux MV 1.2 Tablet.
Drug-Disease Interactions
• Kidney Disease: The medication may exacerbate renal conditions.
• Liver Disease: Not recommended for patients with liver disorders.
• Metabolic Acidosis: The medication may worsen this condition.
Daily Dosage
• Glynux MV 1.2 Tablet should be taken as directed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. It is important to follow the prescribed dosage and not exceed it without consulting your doctor.
Missed Dose
• If a dose is missed, take it as soon as you remember.
• If it is nearly time for the next dose, skip the missed dose and continue with the regular dosing schedule.
• Do not double the dose to catch up.
Overdose
• Common symptoms of overdose may include nausea, dizziness, and stomach discomfort. Seek medical attention if symptoms persist.
• Store at a temperature not exceeding 30°C.
• Keep in its original packaging to protect from light and moisture.
• Keep out of reach of children.
• Do not use past the expiration date.
• Maintain a balanced diet with restricted carbohydrate intake to support blood sugar control.
• Engage in regular physical activity to improve insulin sensitivity and optimise diabetes management.